Tabalumab, also as atacicept, represents a unique therapeutic approach for managing autoimmune diseases. This engineered monoclonal immunoglobulin specifically blocks B cell stimulatory factor of BAFF, a crucial https://www.targetmol.com/compound/tabalumab